A systematic review of validated methods for identifying erythema multiforme major/minor/not otherwise specified, Stevens-Johnson Syndrome, or toxic epidermal necrolysis using administrative and claims data

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue SUPPL. 1, 2012, Pages 236-239

  Schneider, Gary ^a   Kachroo, Sumesh ^a   Jones, Natalie ^a   Crean, Sheila ^a   Rotella, Philip ^a   Avetisyan, Ruzan ^a   Reynolds, Matthew W ^a  

^a UNITED BIOSOURCE CORPORATION   (United States)

Author keywords

Administrative and claims data; Coding algorithm; Erythema multiforme; Mini Sentinel

Indexed keywords

ALGORITHM; ARTICLE; DISEASE CLASSIFICATION; DRUG INFORMATION; ERYTHEMA MULTIFORME; HEALTH INSURANCE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MEDLINE; PRIORITY JOURNAL; STEVENS JOHNSON SYNDROME; SYSTEMATIC REVIEW; TOXIC EPIDERMAL NECROLYSIS; VALIDATION STUDY;

ALGORITHMS; DATABASES, FACTUAL; EPIDERMAL NECROLYSIS, TOXIC; ERYTHEMA MULTIFORME; HUMANS; INSURANCE CLAIM REVIEW; INTERNATIONAL CLASSIFICATION OF DISEASES; OUTCOME ASSESSMENT (HEALTH CARE); PILOT PROJECTS; PRODUCT SURVEILLANCE, POSTMARKETING; STEVENS-JOHNSON SYNDROME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VALIDATION STUDIES AS TOPIC;

EID: 84856041814     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2331     Document Type: Article

References (17)

1. Farthing P, Bagan JV, Scully C. Mucosal disease series. Number IV. Erythema multiforme. Oral Dis 2005; 11: 261-267.
2. Lamoreux MR, Sternbach MR, Hsu WT. Erythema multiforme. Am Fam Physician 2006; 74: 1883-1888.
3. Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schroder W, Roujeau JC. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 2002; 138: 1019-1024.
4. Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis 2010; 5: 39.
5. Assier H, Bastuji-Garin S, Revuz J, Roujeau JC. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol 1995; 131: 539-543.
6. Ayangco L, Rogers RS, 3rd. Oral manifestations of erythema multiforme. Dermatol Clin 2003; 21: 195-205.
7. Chan HL, Stern RS, Arndt KA, et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 1990; 126: 43-47.
8. Carnahan RM, Moores KG. Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative data: methods and lessons learned. Pharmacoepidemiol Drug Saf 2012; 21(S1): 82-89.
9. Strom BL. Data validity issues in using claims data. Pharmacoepidemiol Drug Saf 2001; 10: 389-392.
10. Strom BL, Carson JL, Halpern AC, et al. A population-based study of Stevens-Johnson syndrome. Incidence and antecedent drug exposures. Arch Dermatol 1991; 127: 831-838.
11. Strom BL, Carson JL, Halpern AC, et al. Using a claims database to investigate drug-induced Stevens-Johnson syndrome. Stat Med 1991; 10: 565-576.
12. Stern RS. Utilization of hospital and outpatient care for adverse cutaneous reactions to medications. Pharmacoepidemiol Drug Saf 2005; 14: 677-684.
13. Mockenhaupt M, Kelly JP, Kaufman D, Stern RS. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective. J Rheumatol 2003; 30: 2234-2240.
14. Mittmann N, Knowles SR, Gomez M, Fish JS, Cartotto R, Shear NH. Evaluation of the extent of under-reporting of serious adverse drug reactions: the case of toxic epidermal necrolysis. Drug Saf 2004; 27: 477-487.
15. Gau SS-F, Chao PF, Lin YJ, Chang CJ, Gau CS. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study. J Clin Psychopharmacol 2008; 28: 509-517.
16. Centers for Disease Control and Prevention. ICD-9-CM guidelines, conversion table, and addenda. 2010. [2 February 2011].
17. Kagan RJ, Kotoski GM. Successfully changing an ICD-9 diagnosis code: the ABA experience for Stevens-Johnson syndrome and toxic epidermal necrolysis. J Burn Care Res 2010; 31: 146-150.